PODRAVKA prehrambena industrija, d.d. financials
PODRAVKA prehrambena industrija, d.d.
549300TMC6BYESPQ7W85 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €766.5M | €713.8M |
| Cost of sales | €474.9M | €465.1M |
| Gross profit | €291.6M | €248.7M |
| Other income | €5.0M | €3.1M |
| Operating profit (EBIT) | €80.0M | €59.3M |
| Finance costs | €2.6M | €1.8M |
| Profit before tax | €79.9M | €58.6M |
| Income tax expense | €4.5M | -€9.0M |
| Profit for the year | €75.3M | €67.6M |
| — attributable to owners | €73.9M | €66.4M |
| — attributable to NCI | €1.5M | €1.2M |
| Total comprehensive income | €75.0M | €67.7M |
| Per share | ||
| Basic EPS | €10.50 | €9.40 |
| Diluted EPS | €10.40 | €9.40 |
| Free cash flow / share | €2.43 | €5.79 |
| Cash flow statement | ||
| Cash generated from operations | €94.7M | €120.9M |
| Net cash from operating activities | €88.8M | €115.4M |
| Net cash from investing activities | -€68.2M | -€39.6M |
| Net cash from financing activities | -€36.1M | -€55.2M |
| Dividends paid | €22.3M | €18.5M |
| Proceeds from borrowings | €18.0M | €65.8M |
| Repayments of borrowings | €21.0M | €93.0M |
| Lease liability payments | €7.1M | €6.8M |
| Balance sheet | ||
| Total assets | €835.4M | €778.1M |
| Non-current assets | €480.6M | €437.7M |
| Property, plant & equipment | €380.3M | €342.4M |
| Right-of-use assets | €16.7M | €13.2M |
| Intangible assets & goodwill | €3.7M | €3.8M |
| Current assets | €354.8M | €340.4M |
| Inventories | €166.4M | €150.8M |
| Trade & other receivables | €153.5M | €128.3M |
| Cash & equivalents | €27.1M | €42.5M |
| Total equity | €624.3M | €575.0M |
| — attributable to owners | €613.5M | €564.4M |
| Non-controlling interests | €10.9M | €10.6M |
| Non-current liabilities | €30.8M | €28.0M |
| Lease liabilities (non-current) | €11.6M | €8.1M |
| Current liabilities | €180.3M | €175.1M |
| Lease liabilities (current) | €5.5M | €5.3M |
| Trade & other payables | €119.0M | €117.1M |
| Deferred tax liabilities | €4.1M | €4.4M |
| Derived metrics | ||
| Free cash flow | €17.6M | €41.6M |
| Operating margin | 10.4% | 8.3% |
| Net margin | 9.8% | 9.5% |
| Return on equity | 12.1% | 11.8% |
| Cash conversion ratio | 1.18× | 1.71× |
| Capex coverage | 1.25× | 1.56× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€15.5M | €16.2M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€8.1M | -€9.9M |
| Adjustments For Depreciation and Amortisation Expense | €34.4M | €31.8M |
| Adjustments For Dividend Income | €14.0K | €3.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Loans and Advances | -€4.0K | -€4.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | €271.0K | €86.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | -€133.0K | -€368.0K |
| Adjustments For Increase Decrease In Trade Account Payable | €2.4M | €21.3M |
| Adjustments For Interest Expense | €2.5M | €1.6M |
| Adjustments For Interest Income | €2.5M | €1.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €870.0K | -€760.0K |
| Adjustments For Provisions | €1.8M | €2.0M |
| Adjustments For Reconcile Profit Loss | €36.0M | €34.7M |
| Adjustments For Sharebased Payments | €1.0M | €832.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€78.0K | €63.0K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €15.2M | €7.0K |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €16.0K | €4.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.5M | €1.2M |
| Comprehensive Income Attributable To Owners of Parent | €73.5M | €66.5M |
| Current Financial Assets At Amortised Cost | €0 | €8.0M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €2.0K | €59.0K |
| Current Financial Liabilities At Fair Value Through Profit Or Loss | €30.0K | €9.0K |
| Current Loans Received and Current Portion of Noncurrent Loans Received | €40.5M | €43.5M |
| Current Provisions For Employee Benefits | €8.8M | €7.2M |
| Current Tax Assets Current | €595.0K | €3.3M |
| Current Tax Liabilities Current | €6.1M | €1.8M |
| Deferred Tax Assets | €28.4M | €25.4M |
| Dividends Received Classified As Investing Activities | €14.0K | €3.0K |
| Dividends Recognised As Distributions To Noncontrolling Interests | €1.3M | — |
| Dividends Recognised As Distributions To Owners of Parent Relating To Current Year | €22.5M | €18.6M |
| Equity and Liabilities | €835.4M | €778.1M |
| Finance Income | €2.5M | €1.2M |
| General and Administrative Expense | €61.2M | €53.7M |
| Income Taxes Paid Refund Classified As Operating Activities | €1.9M | €3.9M |
| Increase Decrease In Cash and Cash Equivalents | -€15.4M | €20.6M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €260.0K | €1.7M |
| Increase Decrease Through Transactions With Owners | -€25.7M | -€21.3M |
| Increase Decrease Through Transfers and Other Changes Equity | €1.0M | €832.0K |
| Intangible Assets Other Than Goodwill | €36.7M | €33.4M |
| Interest Paid Classified As Operating Activities | €4.0M | €1.6M |
| Interest Received Classified As Investing Activities | €2.5M | €570.0K |
| Investment Property | €13.7M | €13.8M |
| Issued Capital | €213.6M | €213.6M |
| Liabilities | €211.1M | €203.1M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €7.3M | €7.4M |
| Noncurrent Portion of Noncurrent Loans Received | €72.0K | €534.0K |
| Noncurrent Provisions For Employee Benefits | €7.6M | €7.5M |
| Other Adjustments To Reconcile Profit Loss | -€828.0K | -€75.0K |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €0 | €15.9M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €8.0M | €48.3M |
| Other Comprehensive Income | -€321.0K | €91.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€234.0K | €5.0K |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €21.0K | €0 |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€108.0K | €86.0K |
| Other Expense By Function | €2.5M | €2.0M |
| Other Longterm Provisions | €5.1M | €5.1M |
| Other Noncurrent Financial Assets | €1.0M | €5.7M |
| Other Noncurrent Liabilities | €2.3M | €2.4M |
| Other Reserves | €197.5M | €172.1M |
| Other Shortterm Provisions | €305.0K | €180.0K |
| Payments To Acquire Or Redeem Entitys Shares | €3.2M | €5.3M |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €315.0K | €231.0K |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €599.0K | €970.0K |
| Proceeds From Sale Or Issue of Treasury Shares | €854.0K | €2.6M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €6.8M | €0 |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €71.2M | €73.8M |
| Purchase of Treasury Shares | €3.2M | €5.3M |
| Retained Earnings | €193.6M | €168.1M |
| Share Premium | €17.4M | €17.5M |
| Treasury Shares | €8.6M | €6.9M |
Every line item above is a fact tagged in PODRAVKA prehrambena industrija, d.d.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.